Additional European Equity News - 25th September 2026

ArcelorMittal (MT NA) - Unable to safely and sustainably restart operations at ArcelorMittal Kryvyi Rih following multiple recent missile strikes. Expect a non-cash impairment of USD 1bln. (ArcelorMittal) ASML (ASML NA) - Dutch PM Jetten said he has discussed preventing further US export restrictions on ASML with President Trump and lawmakers. He expressed confidence that a workable agreement can be reached over the proposed MATCH Act, which would restrict sales to China of ASML’s immersion DUV lithography machines. (Bloomberg) AstraZeneca (AZN LN) - Perioperative Imfinzi plus neoadjuvant enfortumab vedotin granted Priority Review in the US for patients with muscle-invasive bladder cancer. Based on VOLGA Phase III trial results which demonstrated statistically significant and clinically meaningful improvements in event-free survival and overall survival. (AstraZeneca) Capita (CPI LN) - Secures GBP 30mln financing facilities from Shawbrook Bank. (Capita) Fresenius Medical Care (FME GY) - Co. refines China strategy, and plans to focus on locally relevant innovation. Now expects EUR 110mln one time costs in Q3'26. (Fresenius Medical Care) Ferrexpo (FXPO LN) - H1 2026 (USD): Revenue 196mln (prev. 335mln Y/Y), Underlying EBITDA -4mln (prev. 24mln Y/Y). Ukraine: "Following some improvements in the availability and price of electricity, we were able to restart limited production by bringing one of the Group’s four pellet lines back online". (Ferrexpo) Glencore (GLEN LN) - Co. signs a 5-year Poland wind power PPA with ERG. (Newswires) Novo Nordisk (NOVOB DC) - Co. signed a global licensing and collaboration deal with Nanexa worth up to EUR 1.165bln for long-acting injectable drug-delivery technology. The agreement includes EUR 615mln upfront, milestone payments and low-single-digit royalties, covering certain peptide drugs for obesity and type 2 diabetes. (Novo Nordisk) Repsol (REP SM) - Repsol said about 90% of its crude supply risks breaching new EU methane rules from January, Bloomberg reports. Only around 10-15% of supplies are confirmed compliant, but Repsol is still signing contracts without required provisions to avoid refinery shutdowns. The company has reserved legal rights and may challenge enforcement. TotalEnergies (TTE FP) - Board proposes May 2027 mandate renewals for Puyanne and Aschenbroich. (TotalEnergies) United Utilities (UU/ LN) - Trading Update: Affirms 2026/27 guidance and now targets AMP8 regulatory returns of 10-11%. (United Utilities) Klepierre (LI FP) upgraded to Buy from Hold at Kepler Cheuvreux